Seropositivity of hepatitis B e antigen and hepatocellular carcinoma (Q35794991)

10 August 2017

1 reference

title

Seropositivity of hepatitis B e antigen and hepatocellular carcinoma (English)

1 reference

10 August 2017

1 reference

2

Hwai-I Yang

1 reference

10 August 2017

3

Chien-Jen Chen

1 reference

10 August 2017

San-Lin You

1

1 reference

PubMed ID

15181977

10 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

36

1 reference

10 August 2017

3

1 reference

10 August 2017

215-224

1 reference

Global control of hepatitis B virus infection.

10 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Natural history of chronic hepatitis B virus infection: an immunopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Mutation of nucleotide 1,762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

e Antigen-antibody system as indicator of liver damage in patients with hepatitis-B antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in taiwan: A comparison among asymptomatic carriers, Chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Is anti-HBc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

A case-control study of primary hepatocellular carcinoma in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

p53 mutation in hepatocellular carcinoma after aflatoxin exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Hepatitis B viral genotypes: clinical relevance and molecular characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310021580

10.1080/07853890310021580

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15181977